Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lewis White

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
The Lancet. Infectious Diseases|March 4, 2021
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' replyPhilipp Koehler, P Lewis White, Paul E Verweij, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
The Prognostic Value of (1→3)-β-D-Glucan in COVID-19 Patients with and Without Secondary Fungal DiseaseUdari Welagedara, Jessica Price, Raquel Posso, et al.
Medical Mycology|March 25, 2017
An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumoniaP Lewis White, Jessica S Price, Raquel B Posso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2020
Reply to Rodriguez et al and Mastrangelo et alP Lewis White, Rishi Dhillon, Brendan Healy, et al.
The Lancet. Microbe|February 1, 2021
COVID-19 and fungal infection: the need for a strategic approachP Lewis White, Rishi Dhillon, Harriet Hughes, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2018
Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot studyP Lewis White, Rosemary A Barnes, Rebecca Gorton, et al.
Clinical and Vaccine Immunology : CVI|February 8, 2013
Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samplesP Lewis White, Tim Jones, Katie Whittle, et al.
Journal of Clinical Microbiology|September 24, 2020
An Evaluation of the Performance of the IMMY <i>Aspergillus</i> Galactomannan Enzyme-Linked Immunosorbent Assay When Testing Serum To Aid in the Diagnosis of Invasive AspergillosisP Lewis White, Jessica S Price, Raquel Posso, et al.
Journal of Fungi (Basel, Switzerland)|September 22, 2022
An Evaluation of the OLM <i>Cand</i>ID Real-Time PCR to Aid in the Diagnosis of Invasive Candidiasis When Testing Serum SamplesJessica S Price, Melissa Fallon, Raquel Posso, et al.
Journal of Fungi (Basel, Switzerland)|October 23, 2021
Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and IrelandAlida Fe Talento, Malcolm Qualie, Laura Cottom, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
The Lancet. Infectious Diseases|March 4, 2021
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' replyPhilipp Koehler, P Lewis White, Paul E Verweij, et al.
Journal of Fungi (Basel, Switzerland)|September 26, 2025
The Prognostic Value of (1→3)-β-D-Glucan in COVID-19 Patients with and Without Secondary Fungal DiseaseUdari Welagedara, Jessica Price, Raquel Posso, et al.
Medical Mycology|March 25, 2017
An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumoniaP Lewis White, Jessica S Price, Raquel B Posso, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2020
Reply to Rodriguez et al and Mastrangelo et alP Lewis White, Rishi Dhillon, Brendan Healy, et al.
The Lancet. Microbe|February 1, 2021
COVID-19 and fungal infection: the need for a strategic approachP Lewis White, Rishi Dhillon, Harriet Hughes, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2018
Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot studyP Lewis White, Rosemary A Barnes, Rebecca Gorton, et al.
Clinical and Vaccine Immunology : CVI|February 8, 2013
Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samplesP Lewis White, Tim Jones, Katie Whittle, et al.
Journal of Clinical Microbiology|September 24, 2020
An Evaluation of the Performance of the IMMY <i>Aspergillus</i> Galactomannan Enzyme-Linked Immunosorbent Assay When Testing Serum To Aid in the Diagnosis of Invasive AspergillosisP Lewis White, Jessica S Price, Raquel Posso, et al.
Journal of Fungi (Basel, Switzerland)|September 22, 2022
An Evaluation of the OLM <i>Cand</i>ID Real-Time PCR to Aid in the Diagnosis of Invasive Candidiasis When Testing Serum SamplesJessica S Price, Melissa Fallon, Raquel Posso, et al.
Journal of Fungi (Basel, Switzerland)|October 23, 2021
Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and IrelandAlida Fe Talento, Malcolm Qualie, Laura Cottom, et al.
Pageof 15